In the phase 3 SUBITO trial, researchers aimed to compare outcomes with intensified alkylating chemotherapy to those with an HRD-targeting regimen.

Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.

Each additional hour per day of prolonged sedentary behavior is associated with a higher hazard of cancer death ...

ASCO's 2026 annual conference in Chicago featured cutting-edge research on treatment strategies for sarcomas such as GIST and ...

Investigators conducted a retrospective analysis to determine whether postmenopausal women with a history of breast cancer can safely receive vaginal estrogen.

Investigators compared trial demographics against baseline electronic health record data at 3 NCI–designated cancer centers to identify enrollment gaps.

In this study, researchers aimed to evaluate patterns of engagement with health-related content on social media among US adults both with and without chronic conditions.

In this phase 3 trial, researchers aimed to characterize the clinical characteristics, treatment approaches, and outcomes of patients with metastatic non-rhabdomyosarcoma soft tissue sarcoma and to ...

The US Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

This report presents the long-term follow-up results of JCOG1008, phase 2/3 trial comparing weekly cisplatin versus 3-weekly cisplatin for patients with postoperative high-risk locally advanced ...

This study evaluated the demographic and clinicopathologic characteristics of early-onset breast cancer among young Black women to determine the prevalence of hereditary breast cancer germline ...